HEALTH TECHNOLOGY ASSESSMENT OF MEDICAL DEVICES: A SURVEY OF NON-EUROPEAN UNION AGENCIES

被引:44
|
作者
Ciani, Oriana [1 ,2 ]
Wilcher, Britni [3 ]
Blankart, Carl Rudolf [4 ]
Hatz, Maximilian [4 ]
Rupel, Valentina Prevolnik [5 ]
Erker, Renata Slabe [5 ]
Varabyova, Yauheniya [4 ]
Taylor, Rod S. [1 ]
机构
[1] Univ Exeter, Sch Med, Inst Hlth Res, Evidence Synth & Modelling Hlth Improvement, Exeter EX4 4QJ, Devon, England
[2] Bocconi Univ, Ctr Res Hlth & Social Care Management CERGAS, Milan, Italy
[3] Univ Exeter, Sch Med, Inst Hlth Res, Exeter EX4 4QJ, Devon, England
[4] Univ Hamburg, Hamburg Ctr Hlth Econ, Hamburg, Germany
[5] IER, Berlin, Germany
关键词
Medical devices; Health technology assessment; Reimbursement; COST-EFFECTIVENESS; DRUGS;
D O I
10.1017/S0266462315000185
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: The aim of this study was to review and compare current health technology assessment (HTA) activities for medical devices across non-European Union HTA agencies. Methods: HTA activities for medical devices were evaluated from three perspectives: organizational structure, processes, and methods. Agencies were primarily selected upon membership of existing HTA networks. The data collection was performed in two stages: stage 1-agency Web-site assessment using a standardized questionnaire, followed by review and validation of the collected data by a representative of the agency; and stage 2-semi-structured telephone interviews with key informants of a sub-sample of agencies. Results: In total, thirty-six HTA agencies across twenty non-EU countries assessing medical devices were included. Twenty-seven of thirty-six (75 percent) agencies were judged at stage 1 to have adopted HTA-specific approaches for medical devices (MD-specific agencies) that were largely organizational or procedural. There appeared to be few differences in the organization, process and methods between MD-specific and non-MD-specific agencies. Although the majority (69 percent) of both categories of agency had specific methods guidance or policy for evidence submission, only one MD-specific agency had developed methodological guidelines specific to medical devices. In stage 2, many MD-specific agencies cited insufficient resources (budget, skilled employees), lack of coordination (between regulator and reimbursement bodies), and the inability to generalize findings from evidence synthesis to be key challenges in the HTA of medical devices. Conclusions: The lack of evidence for differentiation in scientific methods for HTA of devices raises the question of whether HTA needs to develop new methods for medical devices but rather adapt existing methodological approaches. In contrast, organizational and/or procedural adaptation of existing HTA agency frameworks to accommodate medical devices appear relatively commonplace.
引用
收藏
页码:154 / 165
页数:12
相关论文
共 50 条
  • [1] A non-European European Union
    Harb, Siba
    [J]. EUROPEAN JOURNAL OF PHILOSOPHY, 2022, 30 (02) : 515 - 529
  • [3] MEDICAL DEVICES: HAVE HEALTH TECHNOLOGY ASSESSMENT AGENCIES STARTED TO FOCUS MORE ON THEM?
    Lie, X.
    Es-Skali, I. J.
    Gubbels, L.
    Nijhuis, T.
    Freeman, C.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A336 - A336
  • [4] Effects of governance on entrepreneurship: European Union vs non-European Union
    Rodriguez-Gulias, Maria Jesus
    de Sousa Gabriel, Vitor Manuel
    Rodeiro-Pazos, David
    [J]. COMPETITIVENESS REVIEW, 2018, 28 (01) : 43 - 57
  • [5] Health Technology Assessment and Medical Devices
    Rogalewicz, Vladimir
    Ujhelyiova, Alena
    Pousek, Lubomir
    Sinkorova, Veronika
    Kneppo, Peter
    [J]. 2011 E-HEALTH AND BIOENGINEERING CONFERENCE (EHB), 2011,
  • [6] Introduction: Health technology assessment and the European Union
    Banta, D
    Oortwijn, W
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2000, 16 (02) : 299 - 302
  • [7] An accelerated access pathway for innovative high-risk medical devices under the new European Union Medical Devices and health technology assessment regulations? Analysis and recommendations
    Tarricone, Rosanna
    Banks, Helen
    Ciani, Oriana
    Brouwer, Werner
    Drummond, Michael F.
    Leidl, Reiner
    Martelli, Nicolas
    Sampietro-Colom, Laura
    Taylor, Rod S.
    [J]. EXPERT REVIEW OF MEDICAL DEVICES, 2023, 20 (04) : 259 - 271
  • [8] Critical Review of European Health-Economic Guidelines for the Health Technology Assessment of Medical Devices
    Blueher, Maximilian
    Saunders, Sita J.
    Mittard, Virginie
    Torres, Rafael Torrejon
    Davis, Jason A.
    Saunders, Rhodri
    [J]. FRONTIERS IN MEDICINE, 2019, 6
  • [9] Conclusion - Health technology assessment and health care in the European Union
    Banta, D
    Oortwijn, W
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2000, 16 (02) : 626 - 635
  • [10] Health technology assessment of medical devices: What is different? An overview of three European projects
    Schnell-Inderst, Petra
    Mayer, Julia
    Lauterberg, Joerg
    Hunger, Theresa
    Arvandi, Marjan
    Conrads-Frank, Annette
    Nachtnebel, Anna
    Wild, Claudia
    Siebert, Uwe
    [J]. ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN, 2015, 109 (4-5): : 309 - 318